- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/24 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulfur atoms by sulfur atoms to which a second hetero atom is attached
Patent holdings for IPC class C07D 211/24
Total number of patents in this class: 75
10-year publication summary
|
3
|
3
|
4
|
3
|
5
|
4
|
7
|
2
|
3
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Prilenia Neurotherapeutics Ltd. | 93 |
16 |
| Takeda Pharmaceutical Company Limited | 2721 |
5 |
| Teva Pharmaceuticals International GmbH | 334 |
4 |
| Teva Pharmaceuticals USA, Inc. | 812 |
4 |
| Novartis AG | 10612 |
3 |
| Epizyme, Inc. | 375 |
3 |
| Generation Bio Co. | 152 |
3 |
| Agency for Science, Technology and Research | 3646 |
2 |
| IVAX International GmbH | 6 |
2 |
| National University of Singapore | 2514 |
2 |
| AstraZeneca AB | 2857 |
1 |
| AstraZeneca UK Limited | 601 |
1 |
| Boehringer Ingelheim International GmbH | 4636 |
1 |
| Syngenta Crop Protection AG | 6259 |
1 |
| Abbott Laboratories | 2357 |
1 |
| Bayer Pharma AG | 1048 |
1 |
| Abbott GmbH & Co. KG | 118 |
1 |
| The Board of Trustees of Illinois State University | 21 |
1 |
| Cognition Therapeutics, Inc. | 39 |
1 |
| Faes Farma, S.A. | 100 |
1 |
| Other owners | 21 |